Lars Håkan Olsson
Président chez Belina Pharma AB
Profil
Lars Håkan Olsson is currently the Chairman of Belina Pharma AB, Belina AB, Director of Oncorena AB, Director of Hakmed AB, and Professor at Lund University Hospital.
He previously served as Director of Oncorena Holding AB and as an Independent Director at Odinwell AB from 2021 to 2022.
Postes actifs de Lars Håkan Olsson
Sociétés | Poste | Début |
---|---|---|
Lund University Hospital | Corporate Officer/Principal | - |
Belina AB | Président | - |
Belina Pharma AB
Belina Pharma AB Miscellaneous Commercial ServicesCommercial Services Belina Pharma AB researches, develops, markets, and trades drugs against breast cancer. The company is headquartered in Helsingborg, Sweden. | Président | - |
Hakmed AB | Directeur/Membre du Conseil | - |
Oncorena AB
Oncorena AB Pharmaceuticals: MajorHealth Technology Oncorena AB develops a novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies in humans. The company was founded in 2011 and is headquartered in Helsingborg, Sweden. | Directeur/Membre du Conseil | - |
Anciens postes connus de Lars Håkan Olsson
Sociétés | Poste | Fin |
---|---|---|
ODINWELL AB | Directeur/Membre du Conseil | 01/01/2022 |
Oncorena Holding AB
Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Oncorena Holding AB develops novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies. The company was founded by Björn Oskar Larsson in 2011 and is headquartered in Helsingborg, Sweden. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ODINWELL AB | Technology Services |
Entreprise privées | 6 |
---|---|
Lund University Hospital | |
Oncorena AB
Oncorena AB Pharmaceuticals: MajorHealth Technology Oncorena AB develops a novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies in humans. The company was founded in 2011 and is headquartered in Helsingborg, Sweden. | Health Technology |
Oncorena Holding AB
Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Oncorena Holding AB develops novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies. The company was founded by Björn Oskar Larsson in 2011 and is headquartered in Helsingborg, Sweden. | Health Technology |
Belina Pharma AB
Belina Pharma AB Miscellaneous Commercial ServicesCommercial Services Belina Pharma AB researches, develops, markets, and trades drugs against breast cancer. The company is headquartered in Helsingborg, Sweden. | Commercial Services |
Belina AB | |
Hakmed AB |